CHIEF SCIENTIFIC OFFICER · SUTRO BIOPHARMA, INC. · Common Stock
Side
M
Value
—
Shares
3,750
Price
—
Executed
Sep 18, 2026
Disclosed
Sep 22, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Sep 18 executedSep 22, 2026 disclosed
STRO · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 37.6% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Gerber Hans-Peter filed this Form 4 reporting a option exercise of STRO on Sep 18, 2026. It became public on Sep 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CHIEF SCIENTIFIC OFFICER
Gerber Hans-Petercik:0001992979
Issuer
SUTRO BIOPHARMA, INC.cik:0001382101
Revision history · 0
No field has changed since this record was first ingested.
